首页> 美国卫生研究院文献>PLoS Clinical Trials >Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure
【2h】

Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure

机译:胰腺自身免疫:辅助生殖技术(ART)-复发性生殖衰竭患者的病因不明

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pancreatic Autoimmunity is defined as the presence of autoantibodies and more frequent need for insulin treatment. Affected women presenting recurrent implantation failure (RIF) or recurrent miscarriage (RM) are often misdiagnosed. The objective of thestudy was to describe clinical and metabolic profiles suggestive of Pancreatic Autoimmunity and therapeutic strategy in patients with RIF/RM. We analyzed retrospectively 735 patients, and have identified a subset (N = 20) with similar metabolic characteristics. At the same time, we included a control group (n = 39), with similar demographic characteristics and negative for pancreatic, thyroid or celiac disease autoimmunity. The patients identified with autoimmune metabolic problem (N = 20) had relatives with diabetes mellitus. At 120 minutes after Oral Glucose Tolerance Test (OGTT) low level of insulin secretion (<2 IU/ml) was found in 70% of patients. Glutamic acid decarboxylase 65 (GAD 65) antibodies, with or without other autoantibodies, were positive in80% of patients and anti-IA2 alone were positive I the rest. Since pregestational period, insulin administration was recommended for 10 patients, metformin for 4 patients and exclusively diet control in 5 of them. Significantly increased live bith rates (LBR) per cycle were observed after metabolic control (52%) compared with live birth rate (LBR) after cycles without control (7.5%) (p<0.0001). We noticed 2 cases of pre-eclampsia and 6 low-birth weights. Insulin administration was needed during the pregnancy in 68% of patients and after childbirth in 31.57% of them. In our control group, all of patients (n = 39) underwent ART (53.8% SET and 46.1% DET) with a 50% (SET) and 61.9% (DET) live birth rate (LBR) per cycle. Patients with RIF/RM, normal BMI, low insulin levels after OGTT could benefit from additional metabolic immune testing. A correct diagnosis and treatment could have a positive impact on their reproductive results and live birth rate.
机译:胰腺自身免疫被定义为自身抗体的存在和对胰岛素治疗的更频繁需求。表现为反复植入失败(RIF)或反复流产(RM)的受影响妇女通常被误诊。该研究的目的是描述提示RIF / RM患者胰腺自身免疫性疾病的临床和代谢特征以及治疗策略。我们回顾性分析了735名患者,并确定了具有相似代谢特征的亚组(N = 20)。同时,我们纳入了一个对照组(n = 39),其人口统计学特征相似,胰腺,甲状腺或腹腔疾病的自身免疫性均为阴性。患有自身免疫代谢问题的患者(N = 20)有糖尿病亲戚。口服葡萄糖耐量测试(OGTT)后120分钟,发现70%的患者胰岛素分泌水平较低(<2 IU / ml)。谷氨酸脱羧酶65(GAD 65)抗体(有或没有其他自身抗体)在80%的患者中呈阳性,而单独的抗IA2在其余患者中呈阳性。从孕期开始,建议10例患者使用胰岛素,四例患者使用二甲双胍,其中5例仅控制饮食。代谢控制后(52%),每个周期的活位速率(LBR)显着高于无控制周期(7.5%)后的活产率(LBR)(p <0.0001)。我们注意到2例先兆子痫和6例低出生体重儿。 68%的患者在妊娠期间和31.57%的患者在分娩后需要使用胰岛素。在我们的对照组中,所有患者(n = 39)接受ART(53.8%SET和46.1%DET),每个周期的活产率(LBR)为50%(SET)和61.9%(DET)。 RIF / RM,BMI正常,OGTT后胰岛素水平低的患者可受益于其他代谢免疫测试。正确的诊断和治疗可能对其生殖结果和活产率产生积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号